AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2021
May 19, 2021
34705_dirs_2021-05-19_3e351a52-5f3f-489d-8276-441613acb402.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-05-13
Reporting Person: GOEL ROHIT (Senior Director of Finance&PAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-13 | Common stock | A | 75000 | — | Acquired | 235000 | Direct |
Footnotes
F1: Represents restricted shares of common stock subject to vesting over three years.
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15